Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

BUY
$8.48 - $11.13 $44,282 - $58,120
5,222 Added 7.66%
73,374 $625,000
Q2 2022

Aug 10, 2022

SELL
$9.95 - $12.27 $1,024 - $1,263
-103 Reduced 0.15%
68,152 $714,000
Q1 2022

May 11, 2022

BUY
$9.81 - $15.4 $298,371 - $468,391
30,415 Added 80.38%
68,255 $743,000
Q4 2021

Feb 04, 2022

BUY
$12.09 - $14.68 $21,242 - $25,792
1,757 Added 4.87%
37,840 $512,000
Q3 2021

Nov 12, 2021

BUY
$13.25 - $15.13 $71,430 - $81,565
5,391 Added 17.56%
36,083 $489,000
Q2 2021

Aug 04, 2021

BUY
$12.97 - $16.15 $398,075 - $495,675
30,692 New
30,692 $439,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Tbh Global Asset Management, LLC Portfolio

Follow Tbh Global Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tbh Global Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tbh Global Asset Management, LLC with notifications on news.